KALA

Kala Pharmaceuticals (KALA)

About Kala Pharmaceuticals (KALA)

KALA BIO, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.

Details

Daily high

$6.04

Daily low

$5.75

Price at open

$5.78

52 Week High

$9.25

52 Week Low

$4.21

Market cap

27.3M

Dividend yield

0.00%

Volume

12,938

Avg. volume

29,029

P/E ratio

-.47

Kala Pharmaceuticals News